e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Gas exchange and paediatric exercise testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension?
D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, K. Spiropoulos (Greece)
Source:
Annual Congress 2010 - Gas exchange and paediatric exercise testing
Session:
Gas exchange and paediatric exercise testing
Session type:
Thematic Poster Session
Number:
892
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, K. Spiropoulos (Greece). Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension?. Eur Respir J 2010; 36: Suppl. 54, 892
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Serum levels of RAAS components in COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Endothelial dysfunction at the patients with COPD with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Contrasting exercise cerebral oxigenation in COPD patients with and without chronic heart failure
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Reduced exercise capacity and impaired pulmonary function in patients with scleroderma
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Pulmonary rehabilitation modulates neurohumoral activation in patients with COPD
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Impaired glucose tolerance in COPD patients with hypoxaemia
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept